Medindia
Medindia LOGIN REGISTER
Advertisement

ChromaDex Reports 2009 Financial Results

Wednesday, March 31, 2010 General News
Advertisement

ChromaDex Corporation and Subsidiaries

Consolidated Statements of Operations

Years Ended January 2, 2010 and January 3, 2009

2009

2008

Sales

$         5,777,865

$       4,506,301

Cost of sales

3,736,435

3,274,800

Gross profit

2,041,430

1,231,501

Operating expenses:

Sales and marketing

829,969

720,519

General and administrative

2,104,193

2,574,985

2,934,162

3,295,504

Operating loss

(892,732)

(2,064,003)

Nonoperating (income) expenses:

Interest expense

17,090

70,079

Interest income

(2,254)

(29,606)

14,836

40,473

Net loss

$          (907,568)

$      (2,104,476)

Basic and Diluted loss per common share

$                 (0.03)

$                (0.07)

Basic and Diluted average common shares outstanding

28,838,216

28,312,934

See Notes to Consolidated Financial Statements.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close